ArticleNigerian medical journal : journal of the Nigeria Medical Association
A Mystery in the Male Breast: Immunomorphological Confirmation of Invasive Papillary Carcinoma in an Elderly.
Article in Nigerian medical journal : journal of the Nigeria Medical Association. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Male invasive papillary carcinoma (IPC) of the breast is an uncommon malignancy, accounting for a small proportion of male breast cancers, and poses significant diagnostic challenges because of its rarity and morphological overlap with other papillary lesions. We report the case of an 85-year-old man who presented with a recurrent painless right breast mass following previous excision without histological evaluation. He underwent simple mastectomy with sentinel lymph node biopsy. Histopathological examination demonstrated an invasive papillary carcinoma comprising over 90% papillary architecture, absence of a myoepithelial layer, and Nottingham Grade 2 morphology. Immunohistochemistry showed diffuse estrogen receptor and progesterone receptor positivity with negative HER2-neu expression, confirming a luminal A molecular subtype. The sentinel lymph node was free of metastasis. The patient received adjuvant tamoxifen and chemotherapy and remains under follow-up. This case highlights the importance of meticulous histomorphological assessment complemented by immunohistochemistry in establishing the diagnosis and guiding management of this rare male breast malignancy, particularly in resource-limited settings.
Indexed as
Identifiers
42677142PMC13527811What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.